July 2021

In the next issue of Pharma Technology Focus, we investigate the potential of a malaria vaccine that made headlines earlier this year when a research team from Oxford University announced that it had developed a vaccine candidate that demonstrated 77% effectiveness in early trials. Sticking with vaccines, we take a look at the emerging side-effects of recently approved Covid-19 drugs and the safety of fast-tracked drug approvals.

Elsewhere in the issue, we find out why the use of blood plasma for the production of plasma-derived therapies is controversial in the UK and ask if it is time to rethink the ban, and profile the complex competition considerations that go into reviewing mergers and acquisitions in the pharma industry.

Plus, we examine the challenges that drug manufacturers face in the race to keep up with our changing understanding of mental health and take a look an intravenous treatment for macular degeneration that could provide practitioners with a way to prevent wounds from scarring. All this, plus the latest insight and analysis from GlobalData.


Editor | Eloise McLennan

Writers | Abi Millar, Chloe Kent, Natalie Healey, Ahmed Bouzidi
Magazine Designer | Marzia Del Gaone

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Maria Gimenez, Filipe Costa, Martina Labaiova​​​, ​Dimeji Akinkuolie, Will Ingham
Lead Designer | John Hammond 

Publisher | Susanne Hauner
Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.